Source: Annual Congress 2002 - Asthma, COPD and management in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. B. Price, Q. Zhang, M. Thomas, J. Leff, D. D. Yin (Aberdeen, United Kingdom; Whitehouse Station, United States Of America). Effect of allergic rhinitis on asthma-related hospitalization, GP visit and drug cost among adult asthmatic patients in the UK. Eur Respir J 2002; 20: Suppl. 38, 2446

Member's Comments

No comment yet.

Related content which might interest you: Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study Source: Eur Respir J 2003; 21: 116-122 Year: 2003 Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma at a single UK hospital Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Association between allergic rhinitis and hospital resource use among asthmatic children in Norway Source: Eur Respir J 2002; 20: Suppl. 38, 335s Year: 2002 Emergency visits for asthma: asthma exacerbations or poor asthma control? Source: Eur Respir J 2004; 24: Suppl. 48, 598s Year: 2004 Effect of β2-agonists on severe asthma exacerbation and asthma-related hospitalization Source: Eur Respir J 2007; 30: Suppl. 51, 352s Year: 2007 Variation of seasonal (monthly) hospitalizations in asthmatic patients: Difference between allergic and non allergic asthma Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD Year: 2012 Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004 Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Prevalence of allergic asthma diagnosis in asthmatic patients visited by allergists and neumologists in Spain Source: Eur Respir J 2003; 22: Suppl. 45, 299s Year: 2003 Difference in healthcare resource use among children with asthma who did and did not have allergic rhinitis diagnosis in a UK primary care database Source: Eur Respir J 2002; 20: Suppl. 38, 332s Year: 2002 One year of unscheduled visits for asthma exacerbations at a specialized clinic – characteristics of ²difficult to control² patients with multiple exacerbations Source: Annual Congress 2008 - Understanding airway inflammation Year: 2008 Follow-up of patients with severe eosinophilic asthma receiving mepolizumab for one year in specialized asthma clinics in Greece. Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020 Incidence of asthma-related hospitalizations with the addition of salmeterol to an ICS in subjects with asthma: a meta-analysis Source: Eur Respir J 2007; 30: Suppl. 51, 352s Year: 2007 Paediatric rhinitis and asthma: impact on parents of allergic children Source: Eur Respir J 2002; 20: Suppl. 38, 329s Year: 2002 The incidence of asthma and allergic rhinitis among young adults in 12 year follow-up Source: Annual Congress 2009 - Epidemiology of asthma Year: 2009 Evaluation of GINA‘s asthma control levels and severity asthma levels in clinical management in children after emergency room visit for asthma crisis Source: Annual Congress 2007 - Childhood asthma: treatment and follow-up Year: 2007 Do patients use of the internet for information in asthma and allergic rhinitis? Source: Eur Respir J 2004; 24: Suppl. 48, 591s Year: 2004 Effectiveness of omalizumab in improving quality of life in patients with ‘steroid-resistant‘ asthma and severe allergic rhinitis Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 Improvements in asthma control and quality of life with omalizumab in allergic (IgE-mediated) asthma patients Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Effect of omalizumab treatment on allergic comorbidities in patients with severe allergic asthma – real life experience from Czech Anti-IgE Registry Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017